pI: 7.108 |
Length (AA): 521 |
MW (Da): 58853 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
21 | 521 | 1qzf (A) | 4 | 521 | 45.00 | 0 | 1 | 1.42 | -0.75 |
234 | 521 | 1f28 (A) | 3 | 297 | 59.00 | 0 | 1 | 1.4 | -1.88 |
1 | 520 | 3irm (A) | 1 | 520 | 99.99 | 0 | 1 | 2.20578 | -1.14 |
17 | 234 | 3rg9 (A) | 23 | 240 | 62.00 | 0 | 1 | 1.28013 | -1.48 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Resolution | Method | # Atoms | # Residues | Dep. Date | Pub. Date | Mod. Date |
---|---|---|---|---|---|---|
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 80-100% percentile | epimastigote. | Smircich P |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_127385)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G34570 | bifunctional dihydrofolate reductase - thymidylate synthase |
Arabidopsis thaliana | AT2G16370 | bifunctional dihydrofolate reductase-thymidylate synthase 1 |
Babesia bovis | BBOV_II000780 | dihydrofolate reductase/thymidilate synthase |
Brugia malayi | Bm1_33465 | thymidylate synthase |
Candida albicans | CaO19.3549 | Thymidylate synthase capable of functional substitution for S. cerevisiae CDC21 (YOR074C) |
Candida albicans | CaO19.11033 | Thymidylate synthase capable of functional substitution for S. cerevisiae CDC21 (YOR074C) |
Caenorhabditis elegans | CELE_Y110A7A.4 | Protein Y110A7A.4 |
Cryptosporidium hominis | Chro.40506 | chain A, crystal structure of Dhfr |
Cryptosporidium parvum | cgd4_4460 | dihydrofolate reductase-thymidylate synthase |
Drosophila melanogaster | Dmel_CG3181 | CG3181 gene product from transcript CG3181-RA |
Escherichia coli | b2827 | thymidylate synthetase |
Echinococcus granulosus | EgrG_000260100 | thymidylate synthase |
Echinococcus multilocularis | EmuJ_000260100 | thymidylate synthase |
Homo sapiens | ENSG00000176890 | thymidylate synthetase |
Leishmania braziliensis | LbrM.06.0830 | dihydrofolate reductase-thymidylate synthase |
Leishmania donovani | LdBPK_060890.1 | dihydrofolate reductase-thymidylate synthase |
Leishmania infantum | LinJ.06.0890 | dihydrofolate reductase-thymidylate synthase |
Leishmania major | LmjF.06.0860 | dihydrofolate reductase-thymidylate synthase |
Leishmania mexicana | LmxM.06.0860 | dihydrofolate reductase-thymidylate synthase |
Loa Loa (eye worm) | LOAG_05742 | thymidylate synthase |
Mycobacterium leprae | ML1519c | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) |
Mus musculus | ENSMUSG00000025747 | thymidylate synthase |
Mycobacterium tuberculosis | Rv2764c | Probable thymidylate synthase ThyA (ts) (TSASE) |
Mycobacterium ulcerans | MUL_2178 | thymidylate synthase |
Neospora caninum | NCLIV_065390 | Bifunctional dihydrofolate reductase-thymidylate synthase, related |
Oryza sativa | 4350527 | Os11g0484400 |
Oryza sativa | 9271078 | Os12g0446900 |
Onchocerca volvulus | OVOC2868 |
|
Plasmodium berghei | PBANKA_0719300 | bifunctional dihydrofolate reductase-thymidylate synthase, putative |
Plasmodium falciparum | PF3D7_0417200 | bifunctional dihydrofolate reductase-thymidylate synthase |
Plasmodium knowlesi | PKNH_0509600 | bifunctional dihydrofolate reductase-thymidylate synthase, putative |
Plasmodium vivax | PVX_089950 | bifunctional dihydrofolate reductase-thymidylate synthase, putative |
Plasmodium yoelii | PY04370 | thymidylate synthase, putative |
Saccharomyces cerevisiae | YOR074C | thymidylate synthase |
Schistosoma japonicum | Sjp_0097190 | hypothetical protein |
Schistosoma japonicum | Sjp_0303630 | ko:K00560 thymidylate synthase [EC2.1.1.45], putative |
Schistosoma mansoni | Smp_135460 | bifunctional dihydrofolate reductase-thymidylate synthase |
Schmidtea mediterranea | mk4.001483.01 | Thymidylate synthase |
Trypanosoma brucei gambiense | Tbg972.7.6360 | dihydrofolate reductase-thymidylate synthase |
Trypanosoma brucei | Tb927.7.5480 | dihydrofolate reductase-thymidylate synthase |
Trypanosoma cruzi | TcCLB.509153.90 | dihydrofolate reductase-thymidylate synthase |
Toxoplasma gondii | TGME49_249180 | bifunctional dihydrofolate reductase-thymidylate synthase |
Theileria parva | TP04_0504 | dihydrofolate reductase-thymidylate synthase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.7.5480 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.5480 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.5480 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb927.7.5480 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b2827 | Escherichia coli | essential | goodall |
CELE_Y110A7A.4 | Caenorhabditis elegans | embryonic lethal | wormbase |
YOR074C | Saccharomyces cerevisiae | inviable | yeastgenome |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
catalytic activity (GO:0003824) | decreased (PATO:0000468) | inferred from enzyme inhibition (ECO:0000184) | Trypanosoma cruzi | 18638 585344 585345 | ||
Annotator: | millerja@u.washington.edu. | Comment: | . | References: | 16048931 | |
growth (GO:0040007) | lethal (sensu genetics) (PATO:0000718) | amastigote (BTO:0000062) | inferred from in vitro culture assay (ECO:0000182) | Trypanosoma cruzi | 18638 585344 585345 | |
Annotator: | millerja@u.washington.edu. | Comment: | . | References: | 16048931 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.8
Compound | Source | Reference |
---|---|---|
ChEMBL23 | References | |
ChEMBL23 | References | |
ChEMBL23 | References | |
ChEMBL23 | References | |
ChEMBL23 | References | |
ChEMBL23 | References | |
Curated by TDRTargets | References | |
Curated by TDRTargets | References | |
ChEMBL23 | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Escherichia coli | Thymidylate synthase (EC 2.1.1.45) (TS) (TSase) | 367 aa | 30.4% | 362 aa | Compounds | References |
Salmonella enterica subsp. enterica serovar Typhi | Dihydrofolate reductase | 159 aa | 30.6% | 160 aa | Compounds | References |
Enterococcus faecium | Dihydrofolate reductase | 167 aa | 29.7% | 155 aa | Compounds | References |
Neisseria gonorrhoeae | Dihydrofolate reductase | 162 aa | 31.0% | 142 aa | Compounds | References |
Gallus gallus | Dihydrofolate reductase | 189 aa | 33.8% | 154 aa | Compounds | References |
Escherichia coli | Dihydrofolate reductase | 157 aa | 29.2% | 137 aa | Compounds | References |
Pneumocystis carinii | Dihydrofolate reductase | 206 aa | 29.5% | 193 aa | Compounds | References |
Mycobacterium tuberculosis | Dihydrofolate reductase DfrA (DHFR) (tetrahydrofolate dehydrogenase) | 159 aa | 38.3% | 141 aa | Compounds | References |